Coastal Infusion Administers Tysabri®
| J-Code | J2323 |
|---|---|
| Manufacturer | Biogen |
| First Approved | 11/23/2004 |
Coastal Infusion can administer your Tysabri prescription at any of our south Florida locations.
Tysabri (ocrelizumab) is used to treat relapsing or primary progressive forms of multiple sclerosis (MS). It is used in patients with active disease, who have relapses and/or signs of active inflammation on scans.
The active substance in Tysabri, ocrelizumab, is a monoclonal antibody (a type of protein) that has been designed to recognize and attach to a specific target called CD20 on the surface of B cells (a type of white blood cell). By targeting B cells, ocrelizumab helps to reduce their activity and helps to prevent flare-ups.
What It Treats
- Multiple Sclerosis (MS)
- Crohn’s Disease
Prescribed By
Tysabri is most often prescribed by Neurologists and Gastroenterologists.
How it’s Administered
Tysabri is administered by intravenous infusion. Tysabri infusions take about an hour.
Frequency
Tysabri is administered monthly.
Related Drugs
Additional Resources
The information on this page is compiled from a variety of online sources. Coastal Infusion has made every effort to verify its accuracy, but patients are advised to discuss any planned or current treatments with their doctor. Report inaccuracies